EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The impact of neoadjuvant immune checkpoint inhibitors on kidney cancer and bladder cancer surgeries: a systematic review

Gabriel Zanette Naspolini, Nilson Marquardt Filho, Isabela Carvalhal, Lucas Uglione Da Ros, Andrei Cardoso Centeno, Carlos Teodosio Da Ros, Gustavo Carvalhal

Medical Research Archives · 24.06.2024 · 12 (6)

DOI: 10.18103/mra.v12i6.5376 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Research Archives, online erschienen am 24.06.2024. Verfasst von Gabriel Zanette Naspolini und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: the neoadjuvant use of immune checkpoint inhibitors (ICIs) in patients with kidney cancer and bladder cancer is controversial, and there are reports suggesting increased difficulties in surgeries in these settings. Aims: we performed a systematic review using PRISMA guidelines methodology to analyze pertinent literature available up to January 05, 2024 in PubMed, updating our previously published systematic review on the subject. Results: we have selected 25 publications for the neoadjuvant use of different immune checkpoint inhibitors before nephrectomies for kidney cancer and seven publications concerning the neoadjuvant use of immune checkpoint inhibitors before cystectomies for bladder cancer. Reports of additional surgical difficulties were noted in 6/25 reports for kidney cancer and 0/7 reports for bladder cancer. Conclusions: in the setting of neoadjuvant immune checkpoint inhibitors, a minority of cases of nephrectomies may be challenging due to inflammatory changes to the surrounding tissues, which may require more experienced surgeons. Neoadjuvant immune checkpoint inhibitors do not seem to pose additional surgical difficulties in cystectomies for the treatment of bladder cancer.

Zitieren

APA

Naspolini, G. Z., Filho, N. M., Carvalhal, I., Ros, L. U. D., Centeno, A. C., Ros, C. T. D., & Carvalhal, G. (2024). The impact of neoadjuvant immune checkpoint inhibitors on kidney cancer and bladder cancer surgeries: a systematic review. Medical Research Archives, 12(6). https://doi.org/10.18103/mra.v12i6.5376

Vancouver

Naspolini GZ, Filho NM, Carvalhal I, Ros LUD, Centeno AC, Ros CTD, et al. The impact of neoadjuvant immune checkpoint inhibitors on kidney cancer and bladder cancer surgeries: a systematic review. Medical Research Archives. 2024;12(6). doi:10.18103/mra.v12i6.5376

BibTeX
@article{Naspolini2024,
  author = {Naspolini, Gabriel Zanette and Filho, Nilson Marquardt and Carvalhal, Isabela and Ros, Lucas Uglione Da and Centeno, Andrei Cardoso and Ros, Carlos Teodosio Da and Carvalhal, Gustavo},
  title = {The impact of neoadjuvant immune checkpoint inhibitors on kidney cancer and bladder cancer surgeries: a systematic review},
  journal = {Medical Research Archives},
  year = {2024},
  volume = {12},
  number = {6},
  doi = {10.18103/mra.v12i6.5376}
}
Kostenlos starten →